483
Sichuan D-Innovation Pharmaceutical Co., Ltd.FDA 483 - Sichuan D-Innovation Pharmaceutical Co., Ltd. - March 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sichuan D-Innovation Pharmaceutical Co., Ltd. in Meishan City, China, revealed significant deficiencies in their manufacturing processes. The firm failed to adequately validate production systems and evaluate deviations from specified process steps. Additionally, there was no assurance that critical systems used for API manufacture were adequately qualified for their intended use.
- Office
- Office of Partnerships
- Person
Open in Dashboard
ID · aa8f3e3f-30dc-41f9-9aca-792b50ab86ed